Giant cell arteritis-related upper/lower limb vasculitis;Atteintes artérielles des membres supérieurs et inférieurs au cours de la maladie de Horton

Presse Medicale

Volumn 40, Issue 2, 2011, Pages 151-161

  Assie, Cyrielle ^a   Marie, Isabelle ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PREDNISONE;

AORTA DISEASE; ARM VASCULITIS; ARTERY OCCLUSION; CLINICAL FEATURE; DISEASE SEVERITY; EARLY DIAGNOSIS; ECHOGRAPHY; FOOT AMPUTATION; GIANT CELL ARTERITIS; HUMAN; ISCHEMIA; LEG VASCULITIS; LIMB AMPUTATION; LOW DRUG DOSE; MORBIDITY; PERIODIC MEDICAL EXAMINATION; SCREENING TEST; SHORT SURVEY; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT INDICATION; VASCULAR SURGERY; VASCULITIS;

ARM; GIANT CELL ARTERITIS; HUMANS; LEG; VASCULITIS;

EID: 79551573078     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2010.11.005     Document Type: Short Survey

References (125)

1. Bengtsson B.A., Malmvall B.E. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. Acta Med Scand 1981, 209:337-345.
2. Chatelain D., Duhaut P., Schmidt J., Loire R., Bosshard S., Guernou M., et al. Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss. Ann Rheum Dis 2009, 68:84-88.
3. Gonzalez-Gay M.A. The diagnosis and management of patients with giant cell arteritis. J Rheumatol 2005, 32:1186-1188.
4. Gonzalez-Gay M.A., Barros S., Lopez-Diaz M.J., Garcia-Porrua C., Sanchez-Andrade A., Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005, 84:269-276.
5. Greene G.M., Lain D., Sherwin R.M., Wilson J.E., McManus B.M. Giant cell arteritis of the legs. Clinical isolation of severe disease with gangrene and amputations. Am J Med 1986, 81:727-733.
6. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1222-1228.
7. Nordborg E., Nordborg C. Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology (Oxford) 2003, 42:413-421.
8. Salvarini C., Cantini F., Boiardi L., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002, 347:261-271.
9. Weyand C.M., Bartley G.B. Giant cell arteritis: new concepts in pathogenesis and implications for management. Am J Ophthalmol 1997, 123:392-395.
10. Weyand C.M., Goronzy J.J. Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999, 42:844-853.
11. Weyand C.M., Goronzy J.J. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003, 139:505-515.
12. Assie C, Janvresse A, Plissonnier D, Levesque H, Marie I. Long6term follow-up of giant cell arteritis. A series of 36 patients. Medicine (Baltimore) 2011;90:40-51.
13. Salvarani C., Della Bella C., Cimino L., Macchioni P., Formisano D., Bajocchi G., et al. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford) 2009, 48:250-253.
14. Salvarini C., Gabriel S.E., O'Fallon W.M., Hunder G.G. The incidence of giant cell arteritis in Olmsted country, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995, 123:192-194.
15. Gonzalez-Gay M.A., Piñeiro A., Gomez-Gigirey A., Garcia-Porrua C., Pego-Reigosa R., Dierssen-Sotos T., et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004, 83:342-347.
16. Klein R.G., Hunder G.G., Stanson A.W., Sheps S.G. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975, 83:806-812.
17. Lie J.T. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995, 24:422-431.
18. Marie I., Proux A., Duhaut P., Primard E., Lahaxe L., Girszyn N., et al. Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine (Baltimore) 2009, 88:182-192.
19. Nuenninghoff D.M., Hunder G.G., Christianson T.J., McClelland R.L., Matteson E.L. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003, 48:3522-3531.
20. Nuenninghoff D.M., Hunder G.G., Christianson T.J., McClelland R.L., Matteson E.L. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003, 48:3532-3537.
21. Östberg G. An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand 1973, 237(Suppl):1-59.
22. Östberg G. Temporal arteritis in a large necropsy series. Ann Rheum Dis 1971, 30:224-235.
23. Cardell B.S., Hanley T. A fatal case of giant-cell or temporal arteritis. J Pathol Bacteriol 1951, 63:587-597.
24. Cohen H.E., Shankar P.J., Martin J.C., Lewis M.H. Atypical giant cell arteritis resulting in arm amputation. Ann R Coll Surg Engl 2003, 85:260-262.
25. De Gennes C., Le Thi Huong D., Wechsler B., Bercy J., Foncin J.F., Piette J.C., et al. Temporal arteritis revealed by upper limb gangrene. J Rheumatol 1989, 16:130-132.
26. Halpin D.P., Moran K.T., Jewell E.R. Arm ischemia secondary to giant cell arteritis. Ann Vasc Surg 1988, 2:381-384.
27. Helfgott S.M., Bauer M.R. Pedal gangrene caused by giant cell arteritis. Arthritis Rheum 1987, 30:1078-1079.
28. Le Hello C., Lévesque H., Jeanton M., Cailleux N., Galateau F., Peillon C., et al. Lower limb giant cell arteritis and temporal arteritis: follow up of 8 cases. J Rheumatol 2001, 28:1407-1412.
29. Rivers S.P., Baur G.M., Inahara T., Porter J.M. Arm ischemia secondary to giant cell arteritis. Am J Surg 1982, 143:554-558.
30. Yun M., Yeh D., Araujo L.I., Jang S., Newberg A., Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 2001, 26:314-319.
31. Akdal G., Thurtell M.J., Halmagyi G.M. Giant cell arteritis presenting with bilateral vertebral and axillary artery occlusions. Intern Med J 2008, 38:741-742.
32. Amann-Vesti B.R., Koppensteiner R., Rainoni L., Pfamatter T., Schneider E. Immediate and long-term outcome of upper extremity balloon angioplasty in giant cell arteritis. J Endovasc Ther 2003, 10:371-375.
33. Amatucci G., Del Mastro G., Iandoli R. Horton giant cell arteritis of the legs. J Cardiovasc Surg 1997, 38:309-312.
34. Atlas L.N. A case of Buerger's disease in an old woman. Am Heart J 1943, 26:120-123.
35. Barrier J., Potel G., Rojouan J., Raffi F., Verlingue C., Renaut-Hovasse H., et al. Sténose des gros troncs artériels survenant au cours d'une corticothérapie efficace de la maladie de Horton. Quatre cas. J Mal Vasc 1983, 8:189-197.
36. Bastin R., Godeau P., Lavernhe J., Leger L., Lemaigre G. Pseudo-polyarthrite rhizomélique de l'artérite temporale à l'artérite des membres inférieurs. Presse Med 1969, 77:1649-1651.
37. Benjilali L., Tazi Mezalek Z., Raffali J., El Imadi H., Harmouche H., Adnaoui M., et al. Atteinte des artères des membres et maladie de Horton: à propos de cinq cas. Rev Med Interne 2009, 30:1004-1010.
38. Both M., Aries P.M., Müller-Hülsbeck S., Jahnke T., Schäfer P.J., Gross W.L., et al. Balloon angioplasty of arteries of the upper 40 extremities in patients with extracranial giant-cell arteritis. Ann Rheum Dis 2006, 65:1124-1130.
39. Bruk M.I. Articular and vascular manifestations of polymyalgia rheumatica. Ann Rheum Dis 1967, 26:104-113.
40. Cabanel G., Voog R., Phelip X., Verdier J.M. Les atteintes artérielles de la maladie de Horton. Sem Hop Paris 1969, 45:436-443.
41. Cailleux N., Levesque H., Borg J.Y., Clavier E., Courtois H. Maladie de Horton avec atteinte des troncs artériels des membres supérieurs. Rôle pathogène des anticorps anticardiolipine ? À propos de deux observations. J Mal Vasc 1992, 17:157-159.
42. Dellapira P.F., Eisenhauer A.C. Bilateral percutaneous balloon angioplasty of the axillary arteries in a patient with giant cell arteritis and upper ischemic symptoms not responsive to corticosteroids. J Rheumatol 1998, 25:1429-1433.
43. De Bruyne L., Pauwels W., Raat F., Mast A. Giant cell (temporal) arteritis diagnosed following upper limb claudication. Acta Clin Belg 2001, 56:370-372.
44. Di Giacomo V., Fraioli A., Carmenini G., Schietroma M., Meloni F., Grossi F. Polymyalgia rheumatica and systemic giant cell arteritis. Bioptic findings of the subclavian arteries in a case of aortic arch syndrome. Angiology 1984, 35:528-533.
45. Dupuy R., Mercie P., Neau D., Longy-Boursier M., Conri C. Giant cell arteritis involving the lower limbs. Rev Rhum Engl Ed 1997, 64:500-503.
46. Ferrandiz D., Joguet R., Yvin J.L. Ischémie subaiguë du membre supérieur survenant à la phase initiale du traiteemnt corticoïde d'une maladie de Horton. Rev Med Interne 1999, 20:87-88.
47. Finlayson R., Robinson J.O. Giant-cell arteritis of the legs. Br Med J 1955, 2:1595-1597.
48. Frangenheim H. Zur frage der reisen-zellarteritis. Zentralb Allg Pathol 1951, 88:81-90.
49. Garcia-Porrua C., Pego-Reigosa R., Pifleiro A., Armesto V., Gonzalez-Gay M. Supraclavicular pulsatile mass as presenting sign of brachiocephalic trunk aneurysm in the long-term follow-up of giant cell arteritis. Arthritis Rheum 2005, 53:475-476.
50. Garcia Vazquez J.M., Carreira J.M., Seoane C., Vidal J.J. Superior and inferior limb ischaemia in giant cell arteritis: angiography follow-up. Clin Rheumatol 1999, 18:61-65.
51. Hamilton C.R., Shelley W.M., Tumulty P.A. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine (Baltimore) 1971, 50:1-27.
52. Hamrin B. Stenosing arteritis of the subclavian axillary arteries (polymyalgia rheumatica sine arteritica). Acta Chir Scand 1976, 142(Suppl. 465):80-83.
53. Hamrin B., Jonsson N., Landberg T. Involvement of large vessels in polymyalgia rheumatica. Lancet 1965, 1:1193-1196.
54. Hatzis G.S., Aroni K.G., Kelekis D.A., Boki K.A. Giant cell arteritis presenting as pulseless disease of the upper extremities. Clin Rheumatol 1996, 15:88-90.
55. Healey L.A., Wilske K.R. Presentation of occult giant cell arteritis. Arthritis Rheum 1980, 23:641-643.
56. Houdent C., Deshayes P., Husson A., Tayot J., Wolf L.M. Artérite giganto-cellulaire des gros troncs. Lyon Med 1979, 241:855-861.
57. Hunder G.G., Sheps S.G. Intermittent claudication and polymyalgia rheumatica. Arch Intern Med 1967, 119:638-643.
58. Hunder G.G., Sheps S.G., Allen G.L., Joyce J.W. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis. Arch Intern Med 1975, 82:613-618.
59. Jennings G.H., Camb M.B. Arteritis of the temporal vessels. Lancet 1938, I:424-428.
60. Jouquan J., Mottier D., Cleuziou A., Pennec Y., Baccino E., Bergeret G., et al. Accidents vasculaires cérébraux précoces au cours de maladies de Horton traitées: responsabilité du traitement corticoïde ?. Ann Med Interne 1984, 135:526-529.
61. Kermani T.A., Matteson E.L., Hunder G.G., Warrington K.J. Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. J Rheumatol 2009, 36:2277-2283.
62. Kolossvary E., Kollar A., Pinet H., Erenyi E., Kisery I., Peter H., et al. Bilateral axillobrachial and external carotid artery manifestation of giant cell arteritis: important role of color duplex ultrasonography in the diagnosis. Int Angiol 2005, 24:202-205.
63. Liozon F., Vidal E., Dany F., Bordessoule D., Adilouze J.L., Drouet M. Arterial stenoses of the arms in Horton's temporal arteritis. A propos of 3 cases. A review of the literature. Ann Med Interne 1986, 137:307-312.
64. Long A., Bruneval P., Laurian C., Cormier J.M., Camilleri J.P., Fiessinger J.N. Extratemporal Horton's disease: diagnosis using subclavian biopsy: 4 cases. Arch Mal Coeur Vaiss 1989, 82:1727-1731.
65. Maksimowicz-McKinnon K., Clark T.M., Hoffman G.S. Takayasu arteritis and giant cell arteritis. A spectrum within the same disease?. Medicine (Baltimore) 2009, 88:221-226.
66. Mickley V., Kogel H., Vogel U. Bilateral brachial claudication as the initial manifestation of giant cell arteritis- case report and review of literature. Vasa 1992, 24:415-421.
67. Missen G.A.K. Arteritis of the arms. Br Med J 1981, 282:2055.
68. Monte R., Gonzalez-Gay M.A., Garcia-Porrua C., Lopez-Alvarez M.J., Pulpeiro J.R. Successful response to angioplasty in a patient with upper limb ischaemia secondary to giant cell arteritis. Br J Rheumatol 1998, 37:344.
69. Ninet J.P., Bachet P., Dumontet C.M., Du Colombier P.B., Stewart M.D., Pasquier J.H. Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica. Am J Med 1990, 88:13-20.
70. O'Brien P.K., Pudden A.J. Peripheral arterial insufficiency due to giant cell arteritis. Can J Surg 1978, 21:441-442.
71. Petrie J.P., Sheppeard H. Giant cell arteritis diagnosed following arm claudication. Aust N Z J Med 1984, 14:275-276.
72. Reichelt H.G., Schmidtchen M. Bilateral symmetrical obliteration syndrome of the subclavian-brachial system in the elderly female. Rontgenblatter 1990, 43:332-334.
73. Rischmueller M., Davies R.P., Smith M.D. Three year follow-up of a case of giant cell arteritis presenting with a chronic cough and upper limb ischaemic symptoms. Br J Rheumatol 1996, 35:800-802.
74. Samanta A., Sheldon P. Polymyalgia rheumatica with bilateral subclavian artery occlusion. Br J Rheumatol 1987, 26:469-470.
75. Sato M., Takeda A., Hagiwara S., Mochizuki M., Minato N., Saito K., et al. Giant cell arteritis and polymyalgia rheumatica presenting as subclavian artery obstruction. Ryumachi 1993, 33:330-334.
76. Series C., Cheradame I., Baste J.C., Midy D. Maladie de Horton révélée par une atteinte des membres inférieurs. Rev Med Interne 1993, 14:317-319.
77. Shibata T., Shibata T., Ozaki S., Ichikawa Y., Itoh G. A case of polymyalgia rheumatica where a complication of large-vessel vasculitis was diagnosed with FDG-PET. Nihon Rinsho Meleki Gakkai Kaishi 2009, 32:129-134.
78. Skopinski S., Constans J., Cherifi H., Midy D., Jarnier P., Le Metayer P., et al. Artériopathie inflammatoire des membres supérieurs au cours de la maladie de Horton. À propos de six cas. J Mal Vasc 1999, 24:45-48.
79. Soury P., Brisset D., Saliou C., Sraieb T., Angel F., Fiessinger J.N., et al. Lésions artérielles des membres supérieurs dans la maladie de Horton. Revascularisation chirurgicale par pontage carotido-huméral bilatéral. Presse Med 1997, 26:1478-1480.
80. Stanley D., Henderson D., Harris S. Giant cell arteritis associated with pericarditis and large vessel disease. Aust N Z J Med 1991, 21:353-355.
81. Stanson A.W., Klein R.G., Hunder G.G. Extracranial angiographic findings in giant cell (temporal) arteritis. Am J Roentgenol 1976, 127:957-963.
82. Stautner-Bruckmann C., Haschka C., Baumann G., Bogner J., Spengel F.A. Rienzenzellarteritis mit isoliertem befall der femoralarterien. Deutsche Medizinische Wochenschrift 1992, 117:974-977.
83. Svendler C.A., Söderlundh S. Angiographic diagnosis in polymyalgia arteritica. Acta Radiol Diagn (Stock) 1977, 18:333-338.
84. Swinson D.R., Goodwill C.J., Talbot I.C. Giant cell arteritis presenting as subclavian artery occlusion. A report of two cases. Postgraduate Med J 1976, 52:525-529.
85. Taieb C., Curet P., Bousquet J.C., Grellet J. Horton's disease with bilateral axillohumeral localization. Arteriographic aspects: 2 cases. J Radiol 1984, 65:573-577.
86. Tarnoff J.F., Pearlman E., Balkoura M.H., Venkataraman M. Bilateral superficial femoral giant cell arteritis. J Cardiovasc Surg 1990, 31:375-379.
87. Tato F., Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 2006, 44:176-182.
88. Tazi Z., Cacoub P., Cheysson D., Godeau B., Piette J.C. Maladie de Horton démasquée par une artériopathie inflammatoire spécifique des membres inférieurs. Rev Med Interne 1997, 18:638-641.
89. Thompson J.R., Simmons C.R., Smith L.L. Polymyalgia arteritica with bilateral subclavian artery occlusive disease. A case report. Radiology 1971, 101:595-596.
90. Viallard J.F., Fach J., Neau D., Monlun E., de Mascarel A., Longy-Boursier M., et al. Giant cell arteritis of the lower limbs in rhizomelic pseudopolyarthritis. Ann Med Interne 1996, 147:225-227.
91. Walz-Leblanc B.A., Ameli F.M., Keystone E.C. Giant cell arteritis presenting as limb claudication. Report and review of the literature. J Rheumatol 1991, 18:470-472.
92. Watts R.A., Coppen M., Bhalla A.K., Binder A.I. Giant cell arteritis presenting as limb claudication. J R Soc Med 1989, 82:51-52.
93. Zaidi F.H., King E.R. Atypical giant cell arteritis resulting in arm amputation. Am R Coll Surg Engl 2005, 85:260-262.
94. Agard C., Said L., Ponge T., Connault J., Masseau A., Pistorius M.A., et al. Fréquence de l'atteinte de l'aorte abdominale au diagnostic de maladie de Horton: étude de 20 patients par échographie-Doppler et angiotomodensitométrie. Presse Med 2009, 38:11-19.
95. Evans J.M., Bowles C.A., Bjornsson J., Mullany C.J., Hunder G.G. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 1994, 37:1539-1547.
96. Navellou J.C., Gil H., Meaux-Ruault N., Magy N., Kantelip B., Dupond J.L. Atteinte de l'aorte thoracique inaugurale de la maladie de Horton. Rev Med Int 2004, 25:141-146.
97. Brack A., Martinez-taboada A., Stanson A., Goronzy J.J., Weyand C.M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999, 42:311-314.
98. Espinoza L.R., Jara L.J., Silveira L.H., Martínez-Osuna P., Zwolinska J.B., Kneer C., et al. Anticardiolipin antibodies in polymyalgia rhumatica cell arteritis: association with severe vascular complications. Am J Med 1991, 90:474-478.
99. Espinosa G., Tàssies D., Font J., Muñoz-Rodríguez F.J., Cervera R., Ordinas A., et al. Antiphopholipid antibodies and thrombophilic factors in giant cell arteritis. Semin Arthritis Rheum 2001, 31:12-20.
100. Liozon F., Jauberteau-Marchan M.O., Boutros-Toni F., Barrier J.H., Dupond J.L., Roblot P., et al. Anticorps anti-cardiolipine et maladie de Horton. Ann Med Interne 1995, 146:541-573.
101. Duhaut P. Anticorps anti-β2GP1 et anti-phospholipides dans la maladie de Horton et la PPR: étude multicentrique cas-témoin GRACG. Rev Med Int 2001, 1:458.
102. Schmidt W.A., Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005, 17:9-15.
103. Schmidt W.A., Kraft H.E., Borowski A., Gromnica-Ihle E.J. Color duplex ultrasonography in large-vessel giant cell arteritis. Scand J Rheumatol 1999, 28:374-376.
104. Schmidt W.A., Kraft H.E., Vorpahl K., Völker L., Gromnica-Ihle E.J. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
105. Schmidt W.A., Natusch A., Möller D.E., Vorpahl K., Gromnica-Ihle E. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol 2002, 20:309-318.
106. Schmidt W.A., Seifert A., Gromnica-Ihle E., Krause A., Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 2008, 47:96-101.
107. Hervé F., Choussy V., Janvresse A., Cailleux N., Levesque H., Marie I. Aortite inflammatoire et maladie de Horton. À propos du suivi évolutif scannographique prospectif d'une série de 11 patients. Rev Med Interne 2006, 27:196-202.
108. Schmidt W.A., Helga E., Kraft, Klaus V., Lutz V., Gromnica-Ihle Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
109. Bley T.A., Markl M., Schelp M., Uhl M., Frydrychowicz A., Vaith P., et al. Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment. Rheumatology 2008, 47:65-67.
110. Bley T.A., Warnatz K., Wieben O., Uhl M., Scholz C., Vaith P., et al. High resolution MRI in giant cell arteritis with mutiple inflammatory stenoses in both calves. Rheumatology (Oxford) 2005, 44:954-959.
111. Stanson A.W. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 2000, 18(4 Suppl. 20):S43-S48.
112. Blockmans D., Maes A., Stroobants S., Nuyts J., Bormans G., Knockaert D., et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999, 38:444-447.
113. Belhocine T., Kaye O., Delanaye P., Corman P., Baghaie M., Deprez M., et al. Maladie de Horton et atteintes artérielles extratemporales: utilité de la tomographie par émission de positons au 18FDG. À propos de trois observations et d'une revue de la littérature. Rev Med Interne 2002, 23:584-591.
114. Hara M., Goodman P.C., Leder R.A. Finding in early phase Takayasu arteritis. J Comput Assist Tomogr 1999, 23:16-18.
115. Blockmans D., de Ceuninck L., Vanderschueren S., Knockaert D., Mortelmans L., Bobbaers H. Repetitive18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006, 55:131-137.
116. Bleeker-Rovers C.P., Bredie S.J.H., van der Meer J.W.M., Corstens F.H.M., Oyen W.J.G. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 2004, 116:50-53.
117. Mazlumzadeh M., Hunder G.G., Easley K.A., Calamia K.T., Matteson E.L., Griffing W.L., et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 2006, 54:3310-3318.
118. De Silva M., Hazleman B.L. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 1986, 45:136-138.
119. van der Veen M.J., Dinant H.J., van Booma-Frankfort C., van Albada-Kuipers G.A., Bijlsma J.W. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?. Ann Rheum Dis 1996, 55:218-223.
120. Jover J.A., Hernández-García C., Morado I.C., Vargas E., Bañares A., Fernández-Gutiérrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001, 134(2):106-114.
121. Spiera R.F., Mitnick H.J., Kupersmith M., Richmond M., Spiera H., Peterson M.G., et al. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 2001, 19:495-501.
122. Hoffman G.S., Cid M.C., Hellmann D.B., Guillevin L., Stone J.H., Schousboe J., et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002, 46:1309-1318.
123. Hellmann D.B. Low dose aspirin in the treatment of giant cell arteritis. Arthritis Rheum 2004, 50:1026-1027.
124. Nesher G. low dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004, 50:1332-1337.
125. Lee M.S., Smith S.D., Galor A., Hoffman G.S. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006, 54:3306-3309.